Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Qianhe Pharmaceutical is a comprehensive pharmaceutical enterprise based in Shijiazhuang, China, specializing in the research, development, and large-scale production of chemical active pharmaceutical ingredients (APIs) and finished dosage forms. The company operates modern, GMP-certified manufacturing facilities that produce a wide range of generic medications across therapeutic areas such as cardiovascular health, anti-infectives, and gastroenterology. Qianhe is recognized for its integrated supply chain, managing everything from chemical synthesis to final packaging, which allows for rigorous quality control. In addition to domestic supply, the company provides contract manufacturing (CMO) services and exports products to international markets. Their portfolio includes essential medicines like amlodipine and entecavir, positioning them as a significant contributor to the regional healthcare infrastructure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 河北乾和制药.